STAAR Surgical Company

NasdaqGM STAA

STAAR Surgical Company Current Liabilities for the quarter ending September 27, 2024: USD 66.34 M

STAAR Surgical Company Current Liabilities is USD 66.34 M for the quarter ending September 27, 2024, a 16.85% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.
  • STAAR Surgical Company Current Liabilities for the quarter ending September 29, 2023 was USD 56.77 M, a 25.28% change year over year.
  • STAAR Surgical Company Current Liabilities for the quarter ending September 30, 2022 was USD 45.32 M, a -3.15% change year over year.
  • STAAR Surgical Company Current Liabilities for the quarter ending October 01, 2021 was USD 46.80 M, a 38.21% change year over year.
  • STAAR Surgical Company Current Liabilities for the quarter ending October 02, 2020 was USD 33.86 M, a 12.97% change year over year.
Key data
Date Current Liabilities Total Non-Current Liabilities Shareholders' Equity Long-Term Debt
Market news
Loading...
SV Wall Street
NasdaqGM: STAA

STAAR Surgical Company

CEO Mr. Thomas G. Frinzi
IPO Date Feb. 24, 1992
Location United States
Headquarters 25651 Atlantic Ocean Drive
Employees 1,056
Sector Consumer Discretionary
Industries
Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Similar companies

HAE

Haemonetics Corporation

USD 62.99

-11.58%

NVST

Envista Holdings Corp

USD 21.79

5.93%

ATR

AptarGroup, Inc.

USD 156.45

-1.18%

MBOT

Microbot Medical Inc.

USD 2.17

6.37%

RGEN

Repligen Corporation

USD 161.86

-0.04%

COO

The Cooper Companies, Inc.

USD 95.29

-1.43%

WST

West Pharmaceutical Services, Inc.

USD 330.47

-1.39%

BDX

Becton, Dickinson and Company

USD 227.21

-7.28%

RMD

ResMed Inc.

USD 237.18

-2.23%

MMSI

Merit Medical Systems, Inc.

USD 109.05

-0.24%

ICUI

ICU Medical, Inc.

USD 158.39

-1.93%

HOLX

Hologic, Inc.

USD 65.45

-10.10%

ANGO

AngioDynamics, Inc.

USD 11.10

1.93%

StockViz Staff

February 7, 2025

Any question? Send us an email